Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inpharmica

Inpharmica
2015 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a bio-medicine technology for designed to offer complex painkiller drug development. The company's bio-medicine technology is used in performing phase III of clinical studies on an increased number of patients, including the monitoring of undesired effects and development of documentation to register a new complex pain killer patented, enabling patients to access next generation pain-killers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Primary Office
  • ul. Czerwonych Maków 12 lok. 13
  • Warszawa, Mazowieckie 01-493
  • Poland

+48 600 000 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inpharmica’s full profile, request a free trial.

Inpharmica Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Inpharmica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Black Pearls VC Venture Capital Minority 000 0000 000000 0

Inpharmica Executive Team (1)

Name Title Board
Seat
Contact
Info
Dorota Święcicka Executive

Inpharmica Board Members (1)

Name Representing Role Since Contact
Info
Weronika Kiełczewska Inpharmica Chairman 000 0000